Contraindications and Safety Considerations for Naproxen in Acute Knee Sprain

Absolute Contraindications

Patients with a known hypersensitivity to naproxen or a history of asthma, urticaria, or allergic reactions to aspirin or other NSAIDs should not receive naproxen. (American Heart Association) 1
Individuals with active or recent gastrointestinal bleeding or ulceration are contraindicated for naproxen therapy. (European League Against Rheumatism) 2

In patients with established cardiovascular disease or multiple cardiovascular risk factors, naproxen should be used only at the lowest effective dose and for the shortest duration necessary to mitigate the increased risk of serious thrombotic events (myocardial infarction, stroke). (American Heart Association) 1
Compared with selective COX‑2 inhibitors, naproxen may have a comparatively more favorable cardiovascular safety profile, although definitive comparative data are limited. (American Heart Association) 1

For patients with a prior symptomatic or complicated upper GI ulcer (no bleed within the past year), co‑prescription of a proton‑pump inhibitor (PPI) with naproxen is recommended to reduce ulcer recurrence. (Clinical Practice Guidelines) 3
In patients who have experienced GI bleeding within the past year, naproxen is relatively contraindicated; if use is unavoidable, it should be combined with a PPI and monitored closely. (Clinical Practice Guidelines) 3

Naproxen can impair renal perfusion, promote sodium retention, and raise blood pressure; therefore, renal function and blood pressure should be monitored in patients with pre‑existing hypertension, chronic kidney disease, or heart failure. (American Heart Association) 1

Naproxen does not interfere with the antiplatelet effect of low‑dose aspirin, making it a safer NSAID choice for patients on aspirin for cardioprotection. (American Heart Association) 1
By contrast, ibuprofen can block aspirin’s irreversible acetylation of platelet COX‑1, potentially diminishing cardiovascular protection; naproxen avoids this interaction. (American Heart Association) 1

Acetaminophen (up to 4 g/day) provides modest analgesia but is significantly less effective than naproxen for inflammatory soft‑tissue injuries such as acute knee sprains. (European League Against Rheumatism) 2
Topical diclofenac may be considered as an alternative with reduced systemic exposure in patients at high risk for systemic NSAID adverse effects; however, the supporting evidence is stronger for osteoarthritis than for acute sprains. (Clinical Practice Guidelines) 3